Tay sachs disease md pathology exam question give robbins based answer

Reading File
Reading File
Finding Sources
Searching PubMed

"Tay-Sachs Disease"[MeSH Terms]

Searching the Web

Tay-Sachs disease GeneReviews HEXA GM2 ganglioside current clinical features

Finding Sources
Finding Sources
Reading File
Reading File
Reading Web Page

https://www.ncbi.nlm.nih.gov/books/NBK1218

Reading File
Reading File
Reading File

Tay-Sachs disease

Definition: Tay-Sachs disease is an autosomal recessive lysosomal storage disorder and a GM2 gangliosidosis caused by severe deficiency of β-hexosaminidase A (Hex A).

Etiology and biochemical defect

  • Caused by mutations in the HEXA gene on chromosome 15, encoding the α-subunit of Hex A.
  • Hex A normally degrades GM2 ganglioside.
  • Enzyme deficiency causes lysosomal accumulation of GM2 ganglioside, predominantly in neurons because the brain is rich in gangliosides.
  • It is relatively frequent in people of Ashkenazi Jewish ancestry, with a reported carrier frequency of approximately 1 in 30.

Pathogenesis

Accumulation of undegraded GM2 ganglioside distends lysosomes, disrupts neuronal function, and ultimately causes neuronal death. The central nervous system, autonomic neurons, and retina are chiefly affected.

Morphology

Light microscopy
  • Neurons are enlarged or ballooned with fine cytoplasmic vacuolation.
  • The vacuoles are massively distended lysosomes containing ganglioside.
  • Progressive neuronal loss, microglial proliferation, and lipid-laden phagocytes in brain tissue occur later.
Electron microscopy
  • Characteristic lysosomal inclusions with concentric, laminated membrane layers, described as onion-skin or whorled membranous bodies.
Eye
  • Retinal ganglion cells become swollen with GM2 ganglioside.
  • This produces a cherry-red spot at the macula: the perifoveal retina becomes pale from swollen ganglion cells, contrasting with the normal red color of the underlying choroid at the fovea.

Clinical features

  • Infant is usually normal at birth.
  • Onset around 3 to 6 months of age, classically about 6 months.
  • Progressive neurodegeneration with:
    • Developmental delay followed by loss of acquired milestones
    • Hypotonia progressing to weakness and flaccidity
    • Exaggerated startle response
    • Progressive blindness
    • Seizures may occur
    • Cherry-red macular spot
  • Severe mental and motor deterioration progresses to a vegetative state.
  • Death commonly occurs by 2 to 3 years in classic infantile disease.

Important negative feature

  • No hepatosplenomegaly.
    This helps distinguish Tay-Sachs disease from Niemann-Pick disease, where hepatosplenomegaly is prominent.

Diagnosis

  • Demonstration of markedly reduced or absent Hex A enzyme activity.
  • Confirmation by HEXA molecular genetic testing.
  • Carrier detection and antenatal diagnosis can be performed with enzyme assay and DNA-based testing.

One-line exam summary

Tay-Sachs disease is an autosomal recessive GM2 gangliosidosis due to HEXA mutation causing hexosaminidase A deficiency, with GM2 accumulation in neurons, ballooned vacuolated neurons with onion-skin lysosomal inclusions, cherry-red macula, progressive neurodegeneration, and no hepatosplenomegaly.

Tay-Sachs vs Niemann-Pick type A

FeatureTay-SachsNiemann-Pick type A
Defective enzymeHexosaminidase ASphingomyelinase
Stored lipidGM2 gangliosideSphingomyelin
Cherry-red maculaPresentMay be present
HepatosplenomegalyAbsentPresent
HistologyBallooned neurons, onion-skin inclusionsFoam cells
Source: Robbins, Cotran & Kumar Pathologic Basis of Disease, pp. 152-153.
This is a shared conversation. Sign in to Orris to start your own chat.